Iovance Biotherapeutics Inc (IOVA) SEC filings

Iovance Biotherapeutics Inc (IOVA) SEC filings — 10-K, 10-Q, 8-K, and Form 4 as cached from EDGAR. When an exhibit lands, this page shows the headline, the numbers, and why it matters.

Those exhibit numbers sit next to the income-statement cache: Latest reported IOVA revenue for 2025-12-31 was $263.5M. Net income was -$391.0M. Revenue was up 60.6% from 2024-12-31 to 2025-12-31. IOVA currently screens at market cap $1.89B. The IOVA filings page is the source view; the stock page is the research view.

EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what Iovance Biotherapeutics Inc said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.